At RSCM, one of the metrics we focus on is survival rate. We track how likely our portfolio companies are to survive 1 year, 2 years, etc., as well as how these probabilities change over time.  We invest in extremely early-stage technology startups and we look for attractive valuations. There’s inherently a very high risk...Read More